OOIR: Observatory of International Research

Papers

(The H4-Index of World Journal of Gastroenterology is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Pancreatic cancer: A review of epidemiology, trend, and risk factors	253
Gut microbiota in obesity	235
Epidemiology of stomach cancer	165
Gut microbiota, inflammatory bowel disease and colorectal cancer	140
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment	107
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma	93
Updates on global epidemiology, risk and prognostic factors of gastric cancer	77
Pancreatic cancer in 2021: What you need to know to win	77
Current guidelines for the management of celiac disease: A systematic review with comparative analysis	74
Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis	74
Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions	70
Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches	69
Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults	68
Artificial intelligence in gastroenterology: A state-of-the-art review	65
Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives	61
From hepatitis A to E: A critical review of viral hepatitis	60
Immune checkpoint inhibitor-related hepatotoxicity: A review	60
High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data	59
Chinese guidelines on the management of liver cirrhosis (abbreviated version)	56
Helicobacter pylori: Commensal, symbiont or pathogen?	55
Early-onset colorectal cancer: A review of current knowledge	54
Machine learning models and over-fitting considerations	54
Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases	53
Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation	51
Gut microbiota in various childhood disorders: Implication and indications	50

Liver injury in the era of COVID-19	49
Molecular overview of progressive familial intrahepatic cholestasis	49
Predictors of early and late hepatocellular carcinoma recurrence	49
Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome	49
Shared decision-making in the management of patients with inflammatory bowel disease	49
BRCA mutated pancreatic cancer: A change is coming	49
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions	49
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?	48
Antimicrobial peptides and the gut microbiome in inflammatory bowel disease	48
Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome	47
Oral microbiome and pancreatic cancer	47
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis	46
Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats	45
Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review	45
Viral hepatitis update: Progress and perspectives	45
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions	45
Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model	45
Microbiota revolution: How gut microbes regulate our lives	44
Prevention of vertical transmission of hepatitis B virus infection	44